Adding Blinatumomab to Chemotherapy May Improve Survival in Infant ALL
The combination of blinatumomab and chemotherapy appears safe and effective in infants with KMT2A-rearranged ALL, according to researchers.
The combination of blinatumomab and chemotherapy appears safe and effective in infants with KMT2A-rearranged ALL, according to researchers.
Exposure to 4 or more CT scans before the age of 18 is associated with an increased risk of intracranial tumors, leukemia, and lymphoma, a study suggests.
Among children receiving maintenance treatment for acute lymphoblastic leukemia, those living in extreme poverty have an increased risk of relapse, a study suggests.
New research suggests that some cancer patients do not have their menstrual history documented and do not receive treatment for menstrual disturbances.
Polivy plus R-CHP is approved for the first-line treatment of patients with DLBCL NOS or HGBL who have an IPI score of 2 or greater.
Multiple myeloma patients aged 70 years or older have a nearly 3-fold higher rate of early death than younger patients, new research suggests.
People with asthma are more likely to develop cancer, particularly those not using inhaled steroids, a study suggests.
Cardiovascular disease (CVD), particularly atherosclerotic CVD, is associated with an increased risk of multiple cancers, research suggests.
A bispecific CAR T-cell therapy produced responses in 91% of patients with relapsed/refractory non-Hodgkin lymphoma in a phase 1 trial.
Omisirge is a nicotinamide-modified allogeneic hematopoietic progenitor cell therapy derived from cord blood.